Carbylan Therapeutics, Inc. (CBYL) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 58 transactions totaling $33.1M, demonstrating a bullish sentiment with $33.0M in net insider flow. The most recent transaction on Nov 21, 2016 involved a transaction of 4,664 shares valued at $36.6K.
No significant insider buying has been recorded for CBYL in the recent period.
No significant insider selling has been recorded for CBYL in the recent period.
Based on recent SEC filings, insider sentiment for CBYL is bullish with an Insider Alignment Score of 100/100 and a net flow of $33.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Carbylan Therapeutics, Inc. (CBYL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading CBYL stock, having executed 58 transactions in the past 90 days. The most active insider is Albert Cha (Executive), who has made 16 transactions totaling $10.1M.
Get notified when executives and directors at CBYL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 21, 2016 | Maroney Marcee | Executive | Option Exercise | 4,664 | $7.84 | $36.6K | |
| Nov 21, 2016 | Maroney Marcee | Executive | Tender | 409 | $8.59 | $3.5K | |
| Nov 21, 2016 | Maroney Marcee | Executive | Payment | 4,255 | $8.59 | $36.6K | |
| Nov 21, 2016 | L. Basta Steven | Executive | Payment | 1,026 | $8.59 | $8.8K | |
| Nov 21, 2016 | L. Basta Steven | Executive | Tender | 99 | $8.59 | $850 | |
| Nov 21, 2016 | L. Basta Steven | Executive | Option Exercise | 1,125 | $7.84 | $8.8K | |
| Nov 21, 2016 | Renzi David | Executive | Payment | 33,454 | $8.59 | $287.4K | |
| Nov 21, 2016 | Renzi David | Executive | Tender | 3,186 | $8.59 | $27.4K | |
| Nov 21, 2016 | Renzi David | Executive | Option Exercise | 36,640 | $7.84 | $287.3K | |
| Dec 30, 2015 | Renzi David | Executive | Option Exercise | 10,000 | $0.56 | $5.6K | |
| Dec 30, 2015 | Renzi David | Executive | Sale | 10,000 | $3.70 | $37.0K | |
| Apr 14, 2015 | VI Affiilates Fund, L.p. Vivo Ventures | Executive | Conversion | 2,476,452 | $N/A | $0 | |
| Apr 14, 2015 | VI Affiilates Fund, L.p. Vivo Ventures | Executive | Conversion | 2,842 | $N/A | $0 | |
| Apr 14, 2015 | VI Affiilates Fund, L.p. Vivo Ventures | Executive | Conversion | 304,438 | $N/A | $0 | |
| Apr 14, 2015 | VI Affiilates Fund, L.p. Vivo Ventures | Executive | Conversion | 2,230 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 11 | $33.1M | 97.8% |
Exercise(M) | 4 | $338.2K | 1.0% |
Payment(F) | 3 | $332.7K | 1.0% |
Sale(S) | 1 | $37.0K | 0.1% |
Tender(U) | 3 | $31.7K | 0.1% |
Conversion(C) | 36 | $0 | 0.0% |
Insiders at Carbylan Therapeutics, Inc. are accumulating shares at an accelerated pace. With 9 insiders making 58 transactions totaling $33.1M in purchases versus $37.0K in sales, the net buying activity of $33.0M signals strong executive confidence. Albert Cha (Executive) leads the buying activity with $10.1M in transactions across all time.